Working… Menu
Trial record 9 of 19 for:    lomitapide

Global Lomitapide Pregnancy Exposure Registry

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT02399839
Recruitment Status : Enrolling by invitation
First Posted : March 26, 2015
Last Update Posted : December 4, 2020
Information provided by (Responsible Party):
Amryt Pharma

No Study Results Posted on for this Study
Recruitment Status : Enrolling by invitation
Estimated Primary Completion Date : March 2028
Estimated Study Completion Date : March 2028